ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Lyn is also involved in other signaling pathways in CML cells, including through BCR-Abl activation of JAK2 that then activates Lyn by preventing SHP-1 from turning off Lyn activity [90].